CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishInsulin-like growth factor-1 (IGF-1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development and differentiation. IGF-1 is included in the World Anti-Doping Agency Prohibited List. While the evidences for IGF-1 as performance enhancing substrate in healthy humans are still weak, clinical studies demonstrated that the endogenous GH/IGF-1 excess is associated with cardiovascular implications. Previously, we demonstrated that human peripheral lymphocytes (PBL) represent a suitable system to identify a gene signature, related to dihydrotestosterone (DHT) or IGF-1 abuse, independent from the type of sport. In addition, in a proteomic study, we demonstrated that DHT hyperdosage affects cell motility and apoptosis. Here we investigate the doping action of IGF-1 by means of a differential proteomic approach and specific protein arrays, revealing an active cytoskeletal reorganization mediated by Stat-1; moreover, IGF-1 stimulation produces a sustained activation of different signaling pathways as well as an overproduction of cytokines positively related to immune response and inflammation. In conclusion, these data indicate that, following IGF-1 hyperdosage, circulating PBL could be more prone to transendothelial migration.
| Titolo: | Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes | |
| Autori: | ||
| Data di pubblicazione: | 2014 | |
| Rivista: | ||
| Abstract: | Insulin-like growth factor-1 (IGF-1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development and differentiation. IGF-1 is included in the World Anti-Doping Agency Prohibited List. While the evidences for IGF-1 as performance enhancing substrate in healthy humans are still weak, clinical studies demonstrated that the endogenous GH/IGF-1 excess is associated with cardiovascular implications. Previously, we demonstrated that human peripheral lymphocytes (PBL) represent a suitable system to identify a gene signature, related to dihydrotestosterone (DHT) or IGF-1 abuse, independent from the type of sport. In addition, in a proteomic study, we demonstrated that DHT hyperdosage affects cell motility and apoptosis. Here we investigate the doping action of IGF-1 by means of a differential proteomic approach and specific protein arrays, revealing an active cytoskeletal reorganization mediated by Stat-1; moreover, IGF-1 stimulation produces a sustained activation of different signaling pathways as well as an overproduction of cytokines positively related to immune response and inflammation. In conclusion, these data indicate that, following IGF-1 hyperdosage, circulating PBL could be more prone to transendothelial migration. | |
| Handle: | http://hdl.handle.net/11367/29089 | |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| 042_Proteomics2014_proofs.pdf | Documento in Post-print | DRM non definito | Administrator Richiedi una copia |
http://hdl.handle.net/11367/29089
Copyright © 2022